Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index; 32 of the 47 sources its claims cite were checked for support.

Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology

Open access

Abstract

Imaging technologies are being increasingly used in biomedical research and experimental toxicology to gather morphological and functional information from cellular models. There is a concrete opportunity of incorporating imaging-based in vitro methods in international guidelines to respond to regulatory requirements with human relevant data. To translate these methods from R&D to international regulatory acceptance, the community needs to implement test methods under quality management systems, assess inter-laboratory transferability, and demonstrate data reliability and robustness. This article summarises current challenges associated with image acquisition, image analysis, including artificial intelligence, and data management of imaging-based methods, with examples from the developmental neurotoxicity in vitro battery and phenotypic profiling assays. The article includes considerations on specific needs and potential solutions to design and implement future validation and transferability studies.

Overview

CoChat Summary

TL;DR

This review/perspective summarizes challenges and recommendations for translating imaging-based in vitro methods from biomedical research to regulatory toxicology, focusing on image acquisition, analysis/AI, metadata, data management, transferability, reproducibility, and quality assurance. It uses the developmental neurotoxicity in vitro battery and phenotypic profiling/Cell Painting as examples and argues that standardisation, validation, and transparent reporting are needed for OECD test guideline acceptance.

Key findings

  • Imaging-based in vitro methods generate digital images that require processing and analysis; regulatory acceptance requires implementation under quality management systems, assessment of inter-laboratory transferability, and demonstration of data reliability and robustness.
  • The developmental neurotoxicity in vitro battery (DNT IVB) was supported by EFSA, which funded assessment of 120 substances; OECD proposed approximately 100 chemicals as DNT reference chemicals, and performance analysis confirmed high reproducibility and accuracy while identifying needs for glia-specific toxicity methods and exclusively human-based cell systems.
  • Cell Painting/phenotypic profiling has been tested on over 1000 chemicals, with profiles available in the EPA CompTox Chemicals Dashboard; in vitro points-of-departure from human cells were similar or more conservative than in vivo animal points-of-departure for 68% of chemicals tested.
  • Recommendations include systematic instrument calibration, standardised open formats (e.g., OME.tiff, OME-Zarr, DICOM), comprehensive metadata and ontologies, data management plans, GLP-compatible archiving (up to 15 years in some jurisdictions), and transparent AI validation; a sensitivity/specificity balance of around 80% for both is usually accepted for regulatory decision-making.

Methods

  • Narrative review/perspective; no primary experimental data are reported. It synthesizes current challenges and platform-agnostic recommendations across the imaging workflow, with examples from the DNT IVB and phenotypic profiling/Cell Painting.
  • Draws on cited literature, OECD guidance documents (e.g., GD34, GIVIMP), FDA/ICH/IVDR frameworks, and community initiatives (e.g., QUAREP-LiMi, Euro-BioImaging, Bigpicture); no sample, dataset, or statistical analysis is described.

Limitations

  • The paper states that considerations on the choice of the best biological model and downstream data analysis of parameters extracted from images are out of scope; the focus is on technology and the imaging workflow.
  • The paper states that existing GLP principles may not be fully applicable to emerging technologies, that capturing comprehensive metadata remains a challenge, that commercial software’s proprietary algorithms limit transparency, and that systematic instrument calibration is often overlooked.
  • Evident from the text: as a review/perspective, the recommendations are not empirically validated in a single study, and no formal limitations section or primary data are presented; regulatory acceptance pathways for imaging-based in vitro methods remain aspirational.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00204-024-03922-z

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

21 Valid · 1 Not valid · 10 Not checked · 32 Own results and interpretations

7 more claims · 3 with their cited sources checked

Create a free account to see all 64 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 40

Create a free account to see these claims.

Citations

Cites

Show all 99 references

Research works printed but not linked: 2

  1. National Academies of Sciences, Engineering and Medicine (2023) Building confidence in new evidence streams for human health risk assessment: lessons learned from laboratory mammalian toxicity tests. The National Academies Press, Washington, DC
  2. OECD (2018a) Extended one-generation reproductive toxicity study (EOGRTS) (OECD TG 443). https://www.oecd-ilibrary.org/content/component/9789264304741-34-en

Cited by

See all 9

Metadata

Authors
Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., Le Dévédec, S. E., Mangas, I., Miranda, E., Nyffeler, J., Pesenti, E., Ricci, F., Schmied, C., Schreiner, A., Stokar-Regenscheit, N., Swedlow, J. R., Uhlmann, V., Wieland, F. C., Wilson, A., & Whelan, M.
Affiliations
  • European Commission (BE)
  • Joint Research Centre (IT)
  • Janssen (Belgium) (BE)
  • King's College London (GB)
  • German Federal Institute for Risk Assessment (BfR) (DE)
  • European Bioinformatics Institute (GB)
  • Leibniz Institute of Environmental Medicine (DE)
  • European Food Safety Authority (IT)
  • Axxam (Italy) (IT)
  • EU-OPENSCREEN (DE)
  • Revvity (United States) (US)
  • University of Dundee (GB)
  • University of Zurich (CH)
  • AstraZeneca (United Kingdom) (GB)
Corresponding author
Piergiovanni, Monica
Venue
Archives of Toxicology
Published
2025-02-13
Volume
99
Issue
4
Pages
1271-1285
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W4407428151
Cited by
9
References
99
Citations by year
2026: 4 · 2025: 5
FWCI
1.39
Type
journal article
Language
en
Open access
Licence
Locations
  • Archives of Toxicology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc-nd)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by-nc-nd)
  • OpenAgrar (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
regulatory toxicology, test method validation, quality management systems, image analysis, artificial intelligence, data management, developmental neurotoxicity, regulatory acceptance
MeSH terms
Animals, Artificial Intelligence, Humans, Image Processing, Computer-Assisted, Toxicology, Reproducibility of Results, Toxicity Tests, Biomedical Research, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology. https://app.cochat.ai/papers/10.1007/s00204-024-03922-z
The paper
Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., Le Dévédec, S. E., Mangas, I., Miranda, E., Nyffeler, J., Pesenti, E., Ricci, F., Schmied, C., Schreiner, A., Stokar-Regenscheit, N., . . . Whelan, M. (2025). Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03922-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.